Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation

International Journal of Cardiology

24 August Aug 2018 28 days ago
  • Campodonico J, Bonomi A, Salvioni E, Veglia F, Mapelli M, Vignati C, Agostoni P

In this paper the usefulness of β-blockers in heart failure (HF) patients with permanent atrial fibrillation (AF) has been questioned.

Reference

Campodonico J, Piepoli M, Clemenza F, Bonomi A, Paolillo S, Salvioni E, Corrà U, Binno S, Veglia F, Lagioia R, Sinagra G, Cattadori G, Scardovi AB, Metra M, Senni M, Scrutinio D, Raimondo R, Emdin M, Magrì D, Parati G, Re F, Cicoira M, Minà C, Limongelli G, Correale M, Frigerio M, Bussotti M, Perna E, Battaia E, Guazzi M, Badagliacca R, Di Lenarda A, Maggioni A, Passino C, Sciomer S, Pacileo G, Mapelli M, Vignati C, Lombardi C, Filardi PP, Agostoni P; MECKI Score Research Group. Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation. Int J Cardiol 2018 Aug 6. pii: S0167-5273(18)34278-5. doi: 10.1016/j.ijcard.2018.08.012. [Epub ahead of print]

Go to PubMed